Exenatide
艾塞那肽
Report date: 2026/05/05 20:00:16
NMEFirst In Class
Base Information
Drug NameExenatide
Drug Alias Name +[18]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[35]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2005/04/28
Country/Territory +[51]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstrazeneca PlcEli Lilly And Company
China Registration ClassN/A
Develop Information
Active CompaniesCanadian Institutes Of Health Research (Cihr)University of TorontoChinese University Of Hong Kong (Cuhk) +[13]
Inactive CompaniesSection Of Biostatistics University Of Copenhagen, CopenhagenRadboud University Medical CenterNational Institutes Of Health +[35]
Active Indications +[9]
Inactive Indications +[26]